Alnylam Pharmaceuticals, Inc. (ALNY) stock analysis
In our weekly check, Alnylam Pharmaceuticals, Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 14 pass, warnings: 3, red flags: 6.
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as ALNY.
What our checks show for ALNY
Red flags
- The gross margin fell by 6.1 points, to 77.3%: costs are rising faster than prices.
- Operating cash flow is only 0.24x net profit: part of the reported profit does not arrive as cash.
- Analysts expect the net margin to shrink by 30.6 points from today's 54.3%.
- The price swings a lot: 64.9% annual volatility. Expect large ups and downs.
- The stock has fallen as much as 84% from a peak. Would you have held through that?
- Pay in shares equals 61.4% of free cash flow: it dilutes shareholders.
Warning signs
- Operating profit covers interest only 2.7 times: a weak year could make the payments hard.
- Analysts expect earnings per share to shrink about 23.4% a year.
- Recovering from its deepest fall took about 1.7 years.
Strengths
- Debt is low: 0.35x equity.
- The net margin rose by 155 points over 5 years, to 54.3%.
- Analysts expect revenue to grow about 21% a year over the next years.
- Revenue grew 69.1% a year over the last 3 years.
- Earnings per share grew 29.9% a year over the last 3 years.
- The company keeps 54.3% of its revenue as net profit.
Next earnings report: 2027-02-11
Similar companies
BNTX · INCY · UTHR · INSM · ASND · EXEL
Questions
What grade does Alnylam Pharmaceuticals, Inc. (ALNY) have?
In our weekly check, Alnylam Pharmaceuticals, Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 14 pass, warnings: 3, red flags: 6. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of ALNY stock?
This week's biggest flags for Alnylam Pharmaceuticals, Inc.: Gross margin falling, Profits not backed by cash, Margins expected to shrink. In total 9 of 23 checks show a warning or a red flag.
What does Alnylam Pharmaceuticals, Inc. do?
Alnylam Pharmaceuticals, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as ALNY.
When does Alnylam Pharmaceuticals, Inc. report earnings next?
The next earnings report is expected on 2027-02-11. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis